(a)
(b)
(c)
(d)
(e)
Figure 1: Treatment of rGal-1 ameliorates pathologic features of OVA-induced allergic mice. (a) Experimental protocol of establishment of allergic airway disease model in C57BL/6 mice. (b) Representative H&E staining of lung sections from C57BL/6 mice. Bars: 50 μm. (c) Histological score of lung inflammation. (d) Representative periodic acid-Schiff (PAS) staining of lung sections from C57BL/6 mice. Bars: 50 μm. (e) Quantification of PAS+ cells in the airway. Data were expressed as the of 6 mice per group. Compared to the OVA group, , .